Highest Dose of Wegovy: 2.4 mg, Wegovy HD & What to Expect

Last updated: October 24, 2026

Quick Answer

The highest dose of Wegovy is now 7.2 mg weekly, sold as Wegovy HD, approved by the FDA in March 2026 for adults who have already tolerated the standard 2.4 mg dose for at least four weeks and still need more weight loss [Source: FDA, 2026]. The 2.4 mg dose remains the main maintenance dose for most patients and the only approved dose for cardiovascular risk reduction and MASH liver disease [Source: FDA label, 2026].

Most people searching for the highest dose of Wegovy: 2.4 mg, Wegovy HD & what to expect want to know whether they should push past 2.4 mg, what side effects to brace for, and whether the jump to 7.2 mg is worth it. I’ll walk through the real titration schedule, the data on side effects and cost, and how to decide if Wegovy HD fits your situation.

Key Takeaways

• 7.2 mg (Wegovy HD) is the highest approved Wegovy dose as of 2026, available only after four or more weeks on 2.4 mg [Source: FDA, 2026].
• 2.4 mg is still the primary evidence-based dose for cardiovascular risk reduction and MASH with liver fibrosis [Source: FDA label, 2026].
• Titration to 2.4 mg typically takes 16 to 20 weeks through a stepwise dose schedule [Source: Wegovy Quick Start Guide].
• Nausea (about 44%), diarrhea (30%), and vomiting (24%) are the most reported side effects at 2.4 mg [Source: Drugs.com, 2026].
• Wegovy is meant for long-term, ongoing use alongside diet and activity changes, not a short course [Source: Wegovy FAQ].
• Weight regain is common after stopping, which is why providers plan for maintenance dosing rather than a fixed end date.

What’s the Difference Between Wegovy 2.4 mg and Wegovy HD

Wegovy 2.4 mg is the standard maintenance dose, while Wegovy HD is a 7.2 mg weekly injection using the same active ingredient, semaglutide, designed for additional weight loss after 2.4 mg has already been tolerated [Source: Novo Nordisk, 2026]. Both come in pre-filled pens, and both require the same gradual approach to dosing.

Key distinctions:

• Eligibility: Wegovy HD is only for adults who’ve already been on 2.4 mg for at least four weeks and need more weight reduction [Source: FDA, 2026].
• Approval scope: 2.4 mg covers obesity treatment, cardiovascular risk reduction, and MASH with liver fibrosis. Wegovy HD currently covers obesity treatment only [Source: FDA label, 2026].
• Magnitude of effect: Novo Nordisk states Wegovy HD produces the highest weight loss seen with any Wegovy dose to date [Source: Novo Nordisk, 2026].

Choose Wegovy HD if you’ve plateaued on 2.4 mg after a reasonable trial and your provider confirms you’ve tolerated it well. Stick with 2.4 mg if you’re being treated for heart risk reduction or liver disease, since that’s still the recommended dose for those conditions.

For a deeper side-by-side look at real patient experiences, see this breakdown of Wegovy HD reviews and whether the higher dose is worth it.

How Much Weight Can You Lose on the 2.4 mg Dose of Wegovy

Weight loss results vary by person, but 2.4 mg is the dose used in Wegovy’s major clinical trials for obesity treatment and cardiovascular risk reduction [Source: FDA label, 2026]. Individual results depend on starting weight, adherence, diet, and activity level, so I won’t quote a single average number here without a verified source.

What’s confirmed:

• 2.4 mg is the dose tied to Wegovy’s approved indications for obesity, overweight with a related condition, and cardiovascular risk [Source: FDA label, 2026].
• Weight loss tends to build gradually over months, not weeks, as the dose titrates upward [Source: Wegovy Quick Start Guide].
• Wegovy HD is specifically positioned for people who’ve plateaued on 2.4 mg and need an additional push [Source: Novo Nordisk, 2026].

A common mistake: expecting dramatic loss in the first few weeks of 2.4 mg. The drug works gradually, and most clinically meaningful loss accumulates over 6 months or longer.

What Are the Side Effects of Wegovy 2.4 mg

The most common side effects at 2.4 mg are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain, along with headache and fatigue [Source: FDA label, 2026]. These effects cluster around dose increases and usually ease within a few weeks.

Clinical trial data compiled by Drugs.com shows these approximate rates at the 2.4 mg dose [Source: Drugs.com, 2026]:

Side effect	Reported rate
Nausea	About 44%
Diarrhea	About 30%
Vomiting	About 24%
Constipation	About 24%
Stomach pain	About 20%
Headache	About 14%
Tiredness	About 11%

Other reported effects include dizziness, bloating, belching, heartburn, hair loss, and changes in skin sensation [Source: Wegovy side effects page]. The UK patient leaflet also warns that nausea, vomiting, and diarrhea can cause dehydration, especially in people with kidney problems, and flags a very rare risk of sudden vision loss (NAION) that needs urgent medical evaluation [Source: medicines.org.uk, 2026].

Edge case: if you’re vomiting repeatedly or can’t keep fluids down, that’s not a “normal” side effect to push through. Contact your provider rather than waiting it out.

How Much Does Wegovy 2.4 mg Cost Per Month

Wegovy pricing varies by insurance coverage, pharmacy, and savings card eligibility, so exact monthly costs are something to verify directly with your plan or provider rather than assume from general figures. [VERIFY: current list price and insurance coverage terms, since these change frequently.]

To get a clearer cost picture:

• Check your insurance formulary for Wegovy coverage tiers and prior authorization rules.
• Ask your pharmacy about manufacturer savings programs you may qualify for.
• Compare options through telehealth providers, which sometimes bundle medication with consultations.

For detailed, regularly updated pricing breakdowns, see this guide on Wegovy HD cost, coverage, and savings options and this resource on Wegovy pill cost without insurance. If you’re uninsured, this roundup of GoodRx Wegovy coupons for uninsured patients is worth reviewing too.

How Long Does It Take to Reach the 2.4 mg Dose

Reaching the 2.4 mg maintenance dose typically takes around 16 weeks, following a stepwise schedule that starts at 0.25 mg and increases roughly every four weeks [Source: Wegovy Quick Start Guide]. This gradual approach gives your digestive system time to adjust.

A typical titration path looks like this:

1. Weeks 1-4: 0.25 mg
2. Weeks 5-8: 0.5 mg
3. Weeks 9-12: 1 mg
4. Weeks 13-16: 1.7 mg
5. Week 17 onward: 2.4 mg (maintenance)
6. After 4+ weeks on 2.4 mg, if eligible: optional step up to Wegovy HD (7.2 mg)

Providers may pause an increase or hold you at a lower step, like 1.7 mg, if side effects aren’t manageable [Source: Wegovy Quick Start Guide]. That’s not a failure, it’s a normal part of individualizing treatment.

Is Wegovy 2.4 mg Safe for Long-Term Use

Wegovy 2.4 mg is approved and studied for long-term, ongoing use as part of a weight management or cardiovascular risk reduction plan, not as a short-term fix [Source: FDA label, 2026]. Long-term safety monitoring continues, and side effects generally become less frequent after the initial titration period.

Things to keep in mind:

• Semaglutide is meant to be paired with reduced-calorie eating and regular activity, not used alone [Source: Novo Nordisk, 2026].
• Long-term users should maintain routine checkups to monitor for rare but serious risks, including gallbladder issues and pancreatitis, which your provider will screen for.
• The rare NAION vision risk mentioned in official leaflets requires prompt medical attention if sudden vision changes occur [Source: medicines.org.uk, 2026].

How Does Wegovy 2.4 mg Compare to Ozempic or Mounjaro

Wegovy and Ozempic share the same active ingredient, semaglutide, but Ozempic is approved for type 2 diabetes management while Wegovy is approved for weight management and related conditions [Source: FDA label, 2026]. Mounjaro uses a different active ingredient, tirzepatide, which works on two gut hormone pathways instead of one.

Quick comparison:

• Wegovy (semaglutide): weight management, cardiovascular risk reduction, MASH with fibrosis; max dose now 7.2 mg (HD).
• Ozempic (semaglutide): type 2 diabetes management; different approved dosing range.
• Mounjaro (tirzepatide): type 2 diabetes management, dual-hormone mechanism, generally associated with higher average weight loss in some trials, though direct comparison depends on individual response.

For more on how these brand names relate, see this guide to semaglutide brand names across Ozempic, Wegovy, and Rybelsus.

Who Shouldn’t Take Wegovy 2.4 mg

Wegovy isn’t appropriate for everyone, and a licensed provider needs to review your personal and family medical history before prescribing it. People with a personal or family history of certain thyroid cancers, or a known hypersensitivity to semaglutide, are generally not candidates [Source: FDA label, 2026].

Other situations that warrant extra caution include pregnancy, active gallbladder disease, a history of pancreatitis, and significant kidney impairment, especially given the dehydration risk tied to GI side effects [Source: medicines.org.uk, 2026]. This is not a complete list, always get a full medical review before starting.

What Happens if 2.4 mg Isn’t Working for Weight Loss

If 2.4 mg stops producing meaningful results after an adequate trial, your provider may consider stepping up to Wegovy HD (7.2 mg) if you qualify, or re-evaluating your overall treatment plan [Source: FDA, 2026]. A plateau doesn’t automatically mean the medication has failed, sometimes it means the dose or approach needs adjusting.

Options to discuss with your provider:

• Moving to Wegovy HD after four or more weeks on 2.4 mg, if you’re an eligible candidate.
• Reassessing diet, activity, and sleep factors that influence weight plateaus.
• Exploring a different GLP-1 medication class, such as tirzepatide-based options, if semaglutide alone isn’t sufficient.

Common mistake: increasing your own dose or injection frequency without medical guidance. Dose changes should always go through your prescriber.

Can You Stay on Wegovy 2.4 mg Forever or Do You Stop Eventually

Wegovy is designed for ongoing, long-term use as part of chronic weight management, similar to how other chronic condition medications are used continuously [Source: Novo Nordisk, 2026]. There isn’t a standard fixed stopping point built into the label for most patients.

Your provider will periodically reassess whether continuing, adjusting, or stepping up to Wegovy HD makes sense based on your weight trends, side effects, and overall health goals. Stopping should always be a planned decision made with your provider, not an abrupt choice.

Do You Gain Weight Back After Stopping Wegovy 2.4 mg

Weight regain is a commonly reported concern after stopping GLP-1 medications like Wegovy, since appetite regulation effects fade once the medication clears your system. This is one reason providers frame Wegovy as a long-term management tool rather than a short-term intervention [Source: Novo Nordisk, 2026].

To reduce regain risk if you do stop:

• Work with your provider on a structured tapering or transition plan rather than stopping cold.
• Keep the dietary and activity habits built during treatment, since these support maintenance independent of medication.
• Discuss whether a lower maintenance dose (like 1.7 mg) might help sustain results instead of stopping entirely.

What Are Common Mistakes People Make With the Highest Dose

The biggest mistake with Wegovy HD is rushing into it before giving 2.4 mg a fair trial, or skipping the required four-week tolerance check [Source: FDA, 2026]. Another frequent error is ignoring hydration during GI side effects, which raises dehydration risk, particularly for people with kidney issues [Source: medicines.org.uk, 2026].

Other mistakes to avoid:

• Expecting Wegovy HD to work without continuing diet and activity changes.
• Not reporting persistent vomiting or diarrhea promptly to a provider.
• Assuming higher dose always means proportionally higher results for every individual, response varies.

How Do You Know if You Need the 2.4 mg Dose vs a Lower One

You likely need the full 2.4 mg dose if your provider has prescribed it for cardiovascular risk reduction, MASH with liver fibrosis, or if you haven’t yet reached your weight goal at a lower maintenance dose like 1.7 mg [Source: FDA label, 2026]. Some patients stay at 1.7 mg long-term if that dose meets their goals with better tolerability.

Decision rule: choose 2.4 mg if you’re being treated for a cardiometabolic condition specifically studied at that dose, or if your weight loss has stalled at 1.7 mg and you’ve tolerated side effects reasonably well. Choose to stay lower if side effects are disruptive and your provider agrees the lower dose still meets your treatment goals.

Are There Alternatives to Wegovy if the 2.4 mg Dose Doesn’t Work

Yes. If 2.4 mg or even Wegovy HD doesn’t deliver the results you need, alternatives include tirzepatide-based medications, oral semaglutide formulations, or microdosing approaches some telehealth providers offer under medical supervision. Any switch should go through a licensed provider familiar with your full history.

Worth exploring:

• Comparing semaglutide dosing for injections versus oral tablets.
• Looking into microdosing protocols, covered in this GLP-1 microdosing chart with doses and schedules.
• Reviewing telehealth GLP-1 programs, such as this Ro GLP-1 cost and pricing breakdown, to compare options and support structures.

FAQ

What is the highest dose of Wegovy available?
The highest dose is 7.2 mg, sold as Wegovy HD, approved in March 2026 for adults who’ve already tolerated 2.4 mg for at least four weeks [Source: FDA, 2026].

Is Wegovy HD the same drug as regular Wegovy?
Yes, both use semaglutide as the active ingredient; Wegovy HD is simply a higher 7.2 mg dose intended for additional weight loss [Source: Novo Nordisk, 2026].

Do I need to try 2.4 mg before Wegovy HD?
Yes, FDA approval requires at least four weeks of tolerating the 2.4 mg dose before stepping up to Wegovy HD [Source: FDA, 2026].

What’s the most common side effect at 2.4 mg?
Nausea is the most reported side effect, affecting around 44% of patients in trial data, followed by diarrhea and vomiting [Source: Drugs.com, 2026].

Can Wegovy 2.4 mg help with heart health, not just weight?
Yes, 2.4 mg is the recommended dose for cardiovascular risk reduction in eligible adults, separate from its weight management use [Source: FDA label, 2026].

Will I regain weight if I stop Wegovy?
Weight regain is commonly reported after stopping GLP-1 medications, which is why providers typically treat Wegovy as a long-term therapy [Source: Novo Nordisk, 2026].

How long before I reach the maintenance dose?
Most people reach the 2.4 mg maintenance dose around 16 weeks into treatment through a gradual step-up schedule [Source: Wegovy Quick Start Guide].

Is there a risk of vision problems with Wegovy?
There’s a very rare reported risk of sudden vision loss (NAION) noted in official patient information, which requires urgent medical evaluation if symptoms occur [Source: medicines.org.uk, 2026].

Conclusion

The jump from 2.4 mg to Wegovy HD’s 7.2 mg isn’t a decision to make on your own timeline, it depends on how you’ve tolerated the standard dose and whether your weight loss has genuinely plateaued. For most people, 2.4 mg remains the foundational dose, and it’s the only one currently tied to cardiovascular and liver-disease benefits. If you’re considering a move to Wegovy HD, or wondering whether a different GLP-1 medication fits your situation better, the next step is a direct conversation with your prescriber about your tolerance history and goals. For a closer look at what current Wegovy HD users report, check out this detailed Wegovy HD reviews and cost analysis.

This article is for informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting or changing any medication.

References

1. FAQ. wegovy.com.
2. News Details. novonordisk-us.com.
3. FDA Approves Fourth Product Under National Priority Voucher Program Higher Dose Semaglutide. fda.gov.
4. 215256s030lbl. accessdata.fda.gov.
5. Side Effects. mash.wegovy.com.
6. Resources Support. mash.wegovy.com.
7. Wegovy. drugs.com.
8. 215256s025lbl. accessdata.fda.gov.
9. Pil. medicines.org.uk.
10. Wegovy Quick Start Guide. wegovy.com.